Dr. Silvina B. Pugliese, MD

Dr. Pugliese practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Pugliese's NPI, 1396057105, was assigned on July 9, 2010. Dr. Pugliese graduated from Boston University School Of Medicine in 2010. Dr. Pugliese holds California license A118309.

Dr. Pugliese's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Pugliese's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Pugliese is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Pugliese to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pugliese practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Pugliese's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Pugliese is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Pugliese's licenses on file in 2 states: California and New York.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, psoriasis and rash among the conditions Dr. Pugliese treats.

CMS data shows 2,361 Medicare services from Dr. Pugliese across 18 procedure codes in 2024, for 680 Medicare patients. Medicare paid $101,350 for them.

CMS counts 680 Medicare patients who saw Dr. Pugliese in 2024. The largest group is 65 to 74, with 295 patients. 71% of them have high cholesterol, and 69% have high blood pressure. 25% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pugliese's median patient age at 55, with 62% women.

In 2024, Dr. Pugliese wrote 1,054 Medicare Part D claims for 282 patients. 94% of them were for generic drugs. CMS names the drug for 936 of them, across 29 drugs with 11 or more claims each, at $211,320 in total drug cost. In 2023, CMS named 666 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Pugliese for performance year 2024, reported as part of a group. Dr. Pugliese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pugliese as offering telehealth. CMS counts 207 procedures of skin biopsy by Dr. Pugliese, more than 85% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Pugliese, published from 2011 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, ErbB Receptors and Drug Eruptions. Dr. Pugliese has published most often in Curr Treat Options Oncol. Dr. Pugliese's most frequent co-authors are Bernice Yu Jing Kwong, MD, Kerri Elyse Rieger, MD, PhD and Lisa C. Zaba, MD, PhD.

CMS Open Payments shows 11 general payments to Dr. Pugliese from 4 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 89% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $7,417.

Dr. Pugliese graduated from Boston University School Of Medicine in 2010.

Dr. Pugliese is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.